4//SEC Filing
Patterson Matthew R 4
Accession 0001209191-22-037519
CIK 0001817229other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:11 PM ET
Size
5.6 KB
Accession
0001209191-22-037519
Insider Transaction Report
Form 4
Patterson Matthew R
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-14+16,911→ 16,911 totalExercise: $4.26Exp: 2032-06-13→ Common Stock (16,911 underlying)
Footnotes (1)
- [F1]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 14, 2023 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001401018
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:11 PM ET
- Size
- 5.6 KB